Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation

• Satoshi Yanagida ,

  * E-mail: yanagi@jikei.ac.jp

  Affiliations Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan

  http://orcid.org/0000-0001-6699-4528

  ⨯
• Michael S. Anglesio,

  Affiliations Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Tayyebeh M. Nazeran,

  Affiliations Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

  ⨯
• Amy Lum,

  Affiliation Department of Molecular Oncology, BC Cancer Agency Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Momoko Inoue,

  Affiliation Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Yasushi Iida,

  Affiliation Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Hirokuni Takano,

  Affiliation Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• Takashi Nikaido,

  Affiliation Department of Pathology, Kosei General Hospital, Tokyo, Japan

  ⨯
• Aikou Okamoto,

  Affiliation Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan

  ⨯
• David G. Huntsman

  Affiliations Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Department of Molecular Oncology, BC Cancer Agency Research Centre, Vancouver, British Columbia, Canada

  ⨯